BBN BBN
Company Profile ↓Company Overview
BBN (BBN) is a publicly traded company listed on with a market capitalization of $907.11M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Net profit has compounded at 39.9% per year over the last five years.
Revenue has grown at a 39.9% CAGR over the past five years.
Maintains a net profit margin of 99.3%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $79.31M (+520.9% YoY); net profit $78.75M.
- Trailing 12 Months Year-on-year growth — revenue +520.9%, earnings +552.5%.
- 5-Year Trend Long-term compounding — revenue CAGR 39.9%, profit CAGR 39.9%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 39.95% |
| 1 Year: | 520.86% |
Compounded Profit Growth
| 5 Years: | 39.89% |
| 1 Year: | 552.46% |
Stock Price Performance
| 1 Year: | -5.04% |
| 6 Months: | -5.50% |
| 3 Months: | -4.76% |
| 1 Month: | +2.93% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)54.58 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Excellent profit margin of 99.3%.
- Compounding revenue at 39.9% over 5 years.
- Profit CAGR of 39.9% over 5 years.
- Generates positive free cash flow.
CONS
- Trading at a high P/E of 77.3.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Revenue | -399.80M | 119.99M | 12.77M | 79.31M |
| Cost of Revenue | - | - | - | - |
| Gross Profit | - | - | - | - |
| Operating Expenses | 383.67K | 535.24K | 705.50K | 566.96K |
| Operating Income | - | - | - | - |
| EBITDA | - | - | - | - |
| Interest Expense | 11.73M | 28.64M | 27.94M | 23.64M |
| Pretax Income | -400.18M | 119.46M | 12.07M | 78.75M |
| Tax Provision | - | - | - | - |
| Net Income | -400.18M | 119.46M | 12.07M | 78.75M |
| Diluted EPS | -6.64 | 1.93 | 0.19 | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Total Assets | 1.64B | 1.63B | 1.57B | 1.64B |
| Current Assets | - | - | - | - |
| Cash & Equivalents | - | 3.83K | - | - |
| Inventory | - | - | - | - |
| Receivables | 28.09M | 26.65M | 29.18M | 35.58M |
| Total Liabilities | 568.59M | 509.39M | 505.70M | 567.69M |
| Current Liabilities | - | - | - | - |
| Long Term Debt | - | - | - | - |
| Total Debt | 564.17M | 501.06M | 504.28M | 566.07M |
| Total Equity | 1.07B | 1.12B | 1.06B | 1.07B |
| Shares Outstanding | 61.79M | 61.79M | 61.79M | 61.79M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Operating Cash Flow | 248.12M | 130.06M | 71.75M | 12.93M |
| Investing Cash Flow | - | - | - | - |
| Financing Cash Flow | -253.42M | -133.53M | -70.15M | -16.20M |
| Capital Expenditure | - | - | - | - |
| Free Cash Flow | 248.12M | 130.06M | 71.75M | 12.93M |
| Net Change in Cash | -5.30M | -3.47M | 1.60M | -3.27M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Gross Margin % | - | - | - | - |
| Operating Margin % | - | - | - | - |
| Net Margin % | 100.1% | 99.6% | 94.5% | 99.3% |
| ROE % | -37.4% | 10.7% | 1.1% | 7.4% |
| ROCE % | - | - | - | - |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for BBN
North American Stock Markets Today: S&P 500, Dow Jones, Nasdaq and TSX Rise as SpaceX and Super Micro Revive the AI Trade - BBN Times
<a href="https://news.google.com/rss/articles/CBMi7wFBVV95cUxQRkZfaGZBVmExSlUzUVhzQ05YcW9xcnMyckYySnNHTEotOUxxejBDNk1URmlHeU1IenlYTkQzREt2LTItNHdWaFI1ei1ZQ0dtNFd3V1hNa0UwWUZCd2p6bEhoRlV0V3c5NFQ3d0hxeFZneDAxUjhGaE9wLTdPZUppZjBKakhXMnJxbms2Q1…
Responsive Playbooks and the BBN Inflection - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxQTDF4d1R1bzZNM05FcUFTVkg1NzRYVjBzdy0zbFhuUlh6Z01HNUZOWldkeHhCZ2t4TFNhSEdZdDJiSnlZdE00Z216eS1nWmQxbDEtX3NJY0ptY0RYUkZ3MThnQ0pXM2Zid2RDNElSNFVWcEFNaUFLTnRIVVc4Y0d2bm5CRmRwUDgyWmU4Tm…
Asian Stock Markets Today: Nikkei 225 Rebounds While SSE Composite, Hang Seng and BSE SENSEX Fall - BBN Times
<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxNOF9uV19oVHZMWXNJMjZPY1RobjdjamxQXzQ2NTJ6WUh5RHRiSjBJTEVCeVZ6LWpnbE1La3QtZ3lEM0hTUlBUWWw0LTM0ZmpLUUQ5SGJ2VjBBTDctSTV2LTlmeDM1Z3NRYTRSczZuZVZUTmc3V21za0d4NnBLN2tKcGZBeUNCR2RfVW5keV…
BBN: The Backdrop Suggests It Will Push Higher From Here (NYSE:BBN) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxQN3ZoUGtqdTRHdk1xeDUxbEU1LWRWSUJyVzF5M01NU2FYQkpXb19ycUFYUmVEVHVMaS1ZS2I0azVhRGpoUDhnUHllZFAwZ0h4NHVzNnFaMHlCaGdHek0xZDYzY0Zzcm5UaDVsWldOYnlfUk5GVGppQm9FOTFtaTFuWUstaFdCc0VONWlIUW…
Baby Bunting Director Gary Kent Increases Indirect Shareholding via Super Fund - The Globe and Mail
<a href="https://news.google.com/rss/articles/CBMi8AFBVV95cUxQWnZzVi1pMkpyeU41TWN4czZCTjlXSHdrR2txVE1RNGppdU1WdXV5SFZTUW9rc3dDeTQyc1V2bm5XTEhLYUE4Um8yTnRjZU1lMWE4WGpyT0Y5NElERkMzdDJsWi1mWWRjVzExeFlxTHFLbGduY3RCZzRsQkg1dHVwbnVKM0htLWNsQ05saW…
Baby Bunting (ASX:BBN) share price jumps 11% on solid FY27 update - Rask Media
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxNZTFWN1BUVzNXSVhWRE9DV2g3ZWU5Y1U3WDN5VHVoczg4V211YXRpLVlCQTJnNjk1eHVfN2Z4Y1hwamZURGhHbkEwWWpnQzBwbzlWOHh1ZW0wOU5kTFdEV3l2Mkk2Wjl6SHZ2NjhUTWtybEhBUTFwamtCSmV1bW1kQVFSU1hZRlkyc3loZG…
BBN — Frequently Asked Questions
What is the current share price of BBN?
As of 2026-10-23 16:27 PDT, BBN trades at $14.68 on NASDAQ/NYSE. Its 52-week range is $14.12 to $16.20.
What is the market capitalisation of BBN?
BBN has a market capitalisation of $907.11M on NASDAQ/NYSE.
What is the P/E ratio of BBN?
BBN trades at a trailing price-to-earnings (P/E) ratio of 77.26. Its price-to-book (P/B) ratio is 0.85.
What is the return on equity (ROE) of BBN?
BBN has a return on equity (ROE) of 7.38%.
Is BBN a good stock to buy?
This page provides a data-driven analysis of BBN, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.